China Digest: Muliang eyes $40m Nasdaq IPO; neoX Biotech, Resproly raise fresh capital

China Digest: Muliang eyes $40m Nasdaq IPO; neoX Biotech, Resproly raise fresh capital

Source: Markus Winkler/Unsplash

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter